Form preview

Get the free 131I-MIBG

Get Form
This document provides information for parents or family caregivers who are caring for children undergoing treatment for neuroblastoma with 131I-MIBG, including safety instructions and guidelines
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign 131i-mibg

Edit
Edit your 131i-mibg form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your 131i-mibg form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing 131i-mibg online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Use the instructions below to start using our professional PDF editor:
1
Create an account. Begin by choosing Start Free Trial and, if you are a new user, establish a profile.
2
Simply add a document. Select Add New from your Dashboard and import a file into the system by uploading it from your device or importing it via the cloud, online, or internal mail. Then click Begin editing.
3
Edit 131i-mibg. Replace text, adding objects, rearranging pages, and more. Then select the Documents tab to combine, divide, lock or unlock the file.
4
Get your file. Select the name of your file in the docs list and choose your preferred exporting method. You can download it as a PDF, save it in another format, send it by email, or transfer it to the cloud.
It's easier to work with documents with pdfFiller than you can have ever thought. You may try it out for yourself by signing up for an account.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out 131i-mibg

Illustration

How to fill out 131I-MIBG

01
Gather all required materials including 131I-MIBG vial, syringes, and safety equipment.
02
Ensure that the area is well-ventilated and that all safety protocols are in place.
03
Verify the patient's identity and confirm the doctor's order for the 131I-MIBG treatment.
04
Clean the injection site on the patient with an antiseptic wipe.
05
Draw the prescribed dose of 131I-MIBG into the syringe, ensuring not to touch the needle.
06
Check for air bubbles in the syringe and expel them carefully if present.
07
Administer the injection slowly into the specified site and apply gentle pressure afterward.
08
Dispose of all used materials in accordance with radioactive waste disposal guidelines.
09
Monitor the patient for any immediate reactions post-injection.

Who needs 131I-MIBG?

01
Patients with certain types of neuroendocrine tumors, such as pheochromocytomas or neuroblastomas.
02
Individuals who have overexpressed adrenergic receptors and require targeted radiotherapy.
03
Patients with metastatic disease that has not responded to other treatments.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.8
Satisfied
56 Votes

People Also Ask about

I-131 MIBG is administered to a child through an intravenous line and absorbed by tumor cells. This therapy destroys tumors while sparing normal, healthy tissue. I-131 MIBG is well tolerated. The major side effect of therapy is low blood counts.
An MIBG scan is a nuclear imaging test that helps healthcare providers diagnose and assess neuroendocrine tumors. Your provider injects a radioactive tracer, called iodine meta-iodobenzylguanidine (MIBG), into your bloodstream. A special camera detects the tracer and takes images inside your body.
I-131 MIBG is administered to a child through an intravenous line and absorbed by tumor cells. This therapy destroys tumors while sparing normal, healthy tissue. I-131 MIBG is well tolerated. The major side effect of therapy is low blood counts.
Iodine-123 has 13 hours of half-life and allows imaging up to 48 hours. Iodine-131 is only used when iodine-123 is not available. The higher energy photons emitted by iodine-131 render it inferior to iodine-123 because of higher dose it gives to patients 9.
I-123 MIBG scintigraphy is an imaging test used to detect certain types of neuroendocrine tumors. Neuroendocrine tumors detected with this scan include neuroblastomas, paragangliomas and pheochromocytomas.
Iodine-123 has 13 hours of half-life and allows imaging up to 48 hours. Iodine-131 is only used when iodine-123 is not available. The higher energy photons emitted by iodine-131 render it inferior to iodine-123 because of higher dose it gives to patients 9.
The 2 most frequently used radiotracers for thyroid tissue scans are I-123 and I-131. The primary differences between the 2 radiotracers are: I-123 has a half-life of approximately 13 hours, decays by gamma emission, and delivers superior image quality.
Radioiodine therapy is a nuclear medicine treatment. Doctors use it to treat an overactive thyroid, a condition called hyperthyroidism. They also may use it to treat thyroid cancer.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

131I-MIBG (Iodine-131 Metaiodobenzylguanidine) is a radioactive compound used primarily in the diagnosis and treatment of certain types of neuroendocrine tumors, particularly neuroblastoma and pheochromocytoma.
Healthcare facilities and professionals administering 131I-MIBG treatments or diagnostic procedures are required to file appropriate documentation related to the use of this radioactive substance.
Filling out 131I-MIBG forms typically involves providing patient information, details about the procedure, dosage administered, and the administering physician's details. It's essential to follow specific guidelines provided by the regulatory body.
The purpose of 131I-MIBG is to provide targeted radiation therapy for certain types of cancer, allowing for the destruction of tumor cells while minimizing damage to surrounding healthy tissue.
The information that must be reported on 131I-MIBG includes the patient's medical history, indications for use, dose administered, route of administration, monitoring observations, and any adverse reactions.
Fill out your 131i-mibg online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.